Clik here to view.
Shanghai Foundation for Rare Disease Appoints CANbridge CEO, James Xue,...
BEIJING CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that James...
View ArticleClik here to view.
GlycoMimetics and Apollomics Announce Exclusive Collaboration and License...
ROCKVILLE, Md. & FOSTER CITY, Calif. & HANGZHOU, China GlycoMimetics, Inc. (NASDAQ: GLYC), a leader in the field of applied glycotechnology for cancer, and Apollomics, Inc., an innovative...
View ArticleClik here to view.
MaveriX Oncology to Present at China Showcase 2020 and Biotech Showcase™ 2020...
PALO ALTO, Calif. MaveriX Oncology, Inc., a development-stage biotechnology company with a proprietary pipeline of targeted small-molecule chemo-immuno-therapeutics for the treatment of a broad...
View ArticleClik here to view.
Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer...
STRASBOURG, France & TOKYO Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TOKYO:...
View ArticleClik here to view.
Transgene and NEC Start Two Clinical Trials with TG4050, an Individualized...
STRASBOURG, France & TOKYO Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and...
View ArticleClik here to view.
SAB Biotherapeutics Announces Research Collaboration With CSL Behring
SIOUX FALLS, S.D. SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, today announced that it has entered into multiple...
View ArticleClik here to view.
Bone Biologics Preclinical Study Shows rhNELL-1 Effectively Promotes Bone...
BURLINGTON, Mass. Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for spine fusion, trauma and osteoporosis markets, has announced that it has completed a preclinical study,...
View ArticleClik here to view.
Ark Biosciences to Present at JPM Healthcare Conference in San Francisco
SHANGHAI Ark Biosciences, a global biotech company developing groundbreaking therapeutics for viral infection and respiratory diseases, today announced its participation in and presentation at the...
View ArticleClik here to view.
プロメセラ：慢性肝不全の急性憎悪（ACLF）患者を対象としたHepaStem™後期第Ⅱ相DHELIVER Studyを開始
モン=サン=ギベール（ベルギー） & 東京 （ビジネスワイヤ） — 細胞由来治療薬および肝疾患分野における世界的イノベーター企業であるPromethera® Biosciences...
View ArticleClik here to view.
Transgene和NEC启动两项AI驱动型抗癌疫苗TG4050治疗卵巢癌和头颈部癌的临床试验
法国斯特拉斯堡和东京 (美国商业资讯)–设计、开发基于病毒的免疫抗癌药的生物技术公司Transgene (Euronext Paris: TNG)和IT和网络技术领先者NEC Corporation (NEC; TOKYO:...
View ArticleClik here to view.
Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
CAMBRIDGE, England & SEOUL, South Korea Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and Daewoong Pharmaceutical Co. Ltd., (KSX: 069620), a leading...
View ArticleClik here to view.
血清研究所とAragen Bioscienceがワクチン開発での協業を発表
印ハイデラバード & 米カリフォルニア州サンノゼ （ビジネスワイヤ） — GVK BIOの子会社でモノクローナル抗体およびその他の高分子製品開発を専門とする一流前臨床CROのAragen Bioscience,...
View ArticleClik here to view.
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class...
INGELHEIM AM RHEIN, Germany & SINGAPORE Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced today the acquisition of worldwide exclusive rights to Enleofen’s preclinical...
View ArticleClik here to view.
Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial...
SHANGHAI & ST. HELIER, Jersey Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company...
View ArticleClik here to view.
PPD Expanding Clinical Development and Laboratory Capabilities in China
WILMINGTON, N.C. PPD, Inc. (PPD) has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and...
View ArticleClik here to view.
Serum研究所宣布与Aragen Bioscience合作开发疫苗
印度海得拉巴和加州圣何塞 (美国商业资讯)–Aragen Bioscience, Inc是GVK BIO的子公司，也是专攻单克隆抗体和其他大分子产品开发的领先的临床前CRO之一，该公司与世界最大的疫苗制造商Serum Institute of India Pvt. Ltd....
View ArticleClik here to view.
三叶草生物制药在研1类新药SCB-313在中国开展的恶性胸水I期临床完成首例患者给药
成都 (美国商业资讯)–三叶草生物制药，一家全球临床阶段，致力于创新及变革性生物制药研发的生物制药公司，今天宣布在中国进行的又一个SCB-313 I期临床试验完成首例患者给药。SCB-313是一种创新重组人肿瘤坏死因子相关凋亡诱导配体（TRAIL）-...
View ArticleClik here to view.
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in...
CHENGDU, China Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was...
View ArticleClik here to view.
Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe
DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful...
View ArticleClik here to view.
GHOキャピタル、中小規模のバイオ製薬企業向けに初期段階の医薬品開発・製造を行う大手CDMOのArdenaを買収
ロンドン （ビジネスワイヤ） — 欧州の医療分野専門投資企業のグローバル・ヘルスケア・オポチュニティーズ（GHOキャピタル・パートナーズ）は、初期段階の医薬品開発に特化した専門開発製造受託機関（CDMO）のArdenaを既存の経営陣と共同でMentha Capitalから買収しました。...
View Article